The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Transforming Growth Factor Beta 1 Market Research Report 2025
Synopsis
The global market for Transforming Growth Factor Beta 1 was valued at US$ 1797 million in the year 2024 and is projected to reach a revised size of US$ 3717 million by 2031, growing at a CAGR of 11.1% during the forecast period.
Transforming growth factor beta 1 or TGF-β1 is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation, and apoptosis. In humans, TGF-β1 is encoded by the TGFB1 gene
North America is the largest Transforming Growth Factor Beta 1 market with about 69% market share. Europe is follower, accounting for about 16% market share.The key manufacturers are Roche, Shionogi Ltd, Acceleron Pharma Inc, Genzyme Corp, Isarna Therapeutics GmbH, Scholar Rock, Sirnaomics Inc, Eli Lilly and Co, Formation Biologics Inc, Novartis AG etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Transforming Growth Factor Beta 1, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transforming Growth Factor Beta 1.
The Transforming Growth Factor Beta 1 market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Transforming Growth Factor Beta 1 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transforming Growth Factor Beta 1 manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Roche
Shionogi Ltd
Acceleron Pharma Inc
Genzyme Corp
Isarna Therapeutics GmbH
Scholar Rock
Sirnaomics Inc
Eli Lilly and Co
Formation Biologics Inc
Novartis AG
Segment by Type
Pirfenidone
Galunisertib
Others
Segment by Application
IPF
Cancer
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Transforming Growth Factor Beta 1 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Transforming Growth Factor Beta 1 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global market for Transforming Growth Factor Beta 1 was valued at US$ 1797 million in the year 2024 and is projected to reach a revised size of US$ 3717 million by 2031, growing at a CAGR of 11.1% during the forecast period.
Transforming growth factor beta 1 or TGF-β1 is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation, and apoptosis. In humans, TGF-β1 is encoded by the TGFB1 gene
North America is the largest Transforming Growth Factor Beta 1 market with about 69% market share. Europe is follower, accounting for about 16% market share.The key manufacturers are Roche, Shionogi Ltd, Acceleron Pharma Inc, Genzyme Corp, Isarna Therapeutics GmbH, Scholar Rock, Sirnaomics Inc, Eli Lilly and Co, Formation Biologics Inc, Novartis AG etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Transforming Growth Factor Beta 1, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transforming Growth Factor Beta 1.
The Transforming Growth Factor Beta 1 market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Transforming Growth Factor Beta 1 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transforming Growth Factor Beta 1 manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Roche
Shionogi Ltd
Acceleron Pharma Inc
Genzyme Corp
Isarna Therapeutics GmbH
Scholar Rock
Sirnaomics Inc
Eli Lilly and Co
Formation Biologics Inc
Novartis AG
Segment by Type
Pirfenidone
Galunisertib
Others
Segment by Application
IPF
Cancer
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Transforming Growth Factor Beta 1 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Transforming Growth Factor Beta 1 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Transforming Growth Factor Beta 1 Market Overview
1.1 Product Definition
1.2 Transforming Growth Factor Beta 1 by Type
1.2.1 Global Transforming Growth Factor Beta 1 Market Value Comparison by Type (2024 VS 2031)
1.2.2 Pirfenidone
1.2.3 Galunisertib
1.2.4 Others
1.3 Transforming Growth Factor Beta 1 by Application
1.3.1 Global Transforming Growth Factor Beta 1 Market Value by Application (2024 VS 2031)
1.3.2 IPF
1.3.3 Cancer
1.3.4 Others
1.4 Global Transforming Growth Factor Beta 1 Market Size Estimates and Forecasts
1.4.1 Global Transforming Growth Factor Beta 1 Revenue 2020-2031
1.4.2 Global Transforming Growth Factor Beta 1 Sales 2020-2031
1.4.3 Global Transforming Growth Factor Beta 1 Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Transforming Growth Factor Beta 1 Market Competition by Manufacturers
2.1 Global Transforming Growth Factor Beta 1 Sales Market Share by Manufacturers (2020-2025)
2.2 Global Transforming Growth Factor Beta 1 Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Transforming Growth Factor Beta 1 Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Transforming Growth Factor Beta 1, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Transforming Growth Factor Beta 1, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Transforming Growth Factor Beta 1, Product Type & Application
2.7 Global Key Manufacturers of Transforming Growth Factor Beta 1, Date of Enter into This Industry
2.8 Global Transforming Growth Factor Beta 1 Market Competitive Situation and Trends
2.8.1 Global Transforming Growth Factor Beta 1 Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Transforming Growth Factor Beta 1 Players Market Share by Revenue
2.8.3 Global Transforming Growth Factor Beta 1 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Transforming Growth Factor Beta 1 Market Scenario by Region
3.1 Global Transforming Growth Factor Beta 1 Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Transforming Growth Factor Beta 1 Sales by Region: 2020-2031
3.2.1 Global Transforming Growth Factor Beta 1 Sales by Region: 2020-2025
3.2.2 Global Transforming Growth Factor Beta 1 Sales by Region: 2026-2031
3.3 Global Transforming Growth Factor Beta 1 Revenue by Region: 2020-2031
3.3.1 Global Transforming Growth Factor Beta 1 Revenue by Region: 2020-2025
3.3.2 Global Transforming Growth Factor Beta 1 Revenue by Region: 2026-2031
3.4 North America Transforming Growth Factor Beta 1 Market Facts & Figures by Country
3.4.1 North America Transforming Growth Factor Beta 1 Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Transforming Growth Factor Beta 1 Sales by Country (2020-2031)
3.4.3 North America Transforming Growth Factor Beta 1 Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Transforming Growth Factor Beta 1 Market Facts & Figures by Country
3.5.1 Europe Transforming Growth Factor Beta 1 Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Transforming Growth Factor Beta 1 Sales by Country (2020-2031)
3.5.3 Europe Transforming Growth Factor Beta 1 Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Transforming Growth Factor Beta 1 Market Facts & Figures by Region
3.6.1 Asia Pacific Transforming Growth Factor Beta 1 Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Transforming Growth Factor Beta 1 Sales by Region (2020-2031)
3.6.3 Asia Pacific Transforming Growth Factor Beta 1 Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Transforming Growth Factor Beta 1 Market Facts & Figures by Country
3.7.1 Latin America Transforming Growth Factor Beta 1 Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Transforming Growth Factor Beta 1 Sales by Country (2020-2031)
3.7.3 Latin America Transforming Growth Factor Beta 1 Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Transforming Growth Factor Beta 1 Market Facts & Figures by Country
3.8.1 Middle East and Africa Transforming Growth Factor Beta 1 Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Transforming Growth Factor Beta 1 Sales by Country (2020-2031)
3.8.3 Middle East and Africa Transforming Growth Factor Beta 1 Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Transforming Growth Factor Beta 1 Sales by Type (2020-2031)
4.1.1 Global Transforming Growth Factor Beta 1 Sales by Type (2020-2025)
4.1.2 Global Transforming Growth Factor Beta 1 Sales by Type (2026-2031)
4.1.3 Global Transforming Growth Factor Beta 1 Sales Market Share by Type (2020-2031)
4.2 Global Transforming Growth Factor Beta 1 Revenue by Type (2020-2031)
4.2.1 Global Transforming Growth Factor Beta 1 Revenue by Type (2020-2025)
4.2.2 Global Transforming Growth Factor Beta 1 Revenue by Type (2026-2031)
4.2.3 Global Transforming Growth Factor Beta 1 Revenue Market Share by Type (2020-2031)
4.3 Global Transforming Growth Factor Beta 1 Price by Type (2020-2031)
5 Segment by Application
5.1 Global Transforming Growth Factor Beta 1 Sales by Application (2020-2031)
5.1.1 Global Transforming Growth Factor Beta 1 Sales by Application (2020-2025)
5.1.2 Global Transforming Growth Factor Beta 1 Sales by Application (2026-2031)
5.1.3 Global Transforming Growth Factor Beta 1 Sales Market Share by Application (2020-2031)
5.2 Global Transforming Growth Factor Beta 1 Revenue by Application (2020-2031)
5.2.1 Global Transforming Growth Factor Beta 1 Revenue by Application (2020-2025)
5.2.2 Global Transforming Growth Factor Beta 1 Revenue by Application (2026-2031)
5.2.3 Global Transforming Growth Factor Beta 1 Revenue Market Share by Application (2020-2031)
5.3 Global Transforming Growth Factor Beta 1 Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Roche Transforming Growth Factor Beta 1 Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Shionogi Ltd
6.2.1 Shionogi Ltd Company Information
6.2.2 Shionogi Ltd Description and Business Overview
6.2.3 Shionogi Ltd Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Shionogi Ltd Transforming Growth Factor Beta 1 Product Portfolio
6.2.5 Shionogi Ltd Recent Developments/Updates
6.3 Acceleron Pharma Inc
6.3.1 Acceleron Pharma Inc Company Information
6.3.2 Acceleron Pharma Inc Description and Business Overview
6.3.3 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Product Portfolio
6.3.5 Acceleron Pharma Inc Recent Developments/Updates
6.4 Genzyme Corp
6.4.1 Genzyme Corp Company Information
6.4.2 Genzyme Corp Description and Business Overview
6.4.3 Genzyme Corp Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Genzyme Corp Transforming Growth Factor Beta 1 Product Portfolio
6.4.5 Genzyme Corp Recent Developments/Updates
6.5 Isarna Therapeutics GmbH
6.5.1 Isarna Therapeutics GmbH Company Information
6.5.2 Isarna Therapeutics GmbH Description and Business Overview
6.5.3 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Product Portfolio
6.5.5 Isarna Therapeutics GmbH Recent Developments/Updates
6.6 Scholar Rock
6.6.1 Scholar Rock Company Information
6.6.2 Scholar Rock Description and Business Overview
6.6.3 Scholar Rock Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Scholar Rock Transforming Growth Factor Beta 1 Product Portfolio
6.6.5 Scholar Rock Recent Developments/Updates
6.7 Sirnaomics Inc
6.7.1 Sirnaomics Inc Company Information
6.7.2 Sirnaomics Inc Description and Business Overview
6.7.3 Sirnaomics Inc Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Sirnaomics Inc Transforming Growth Factor Beta 1 Product Portfolio
6.7.5 Sirnaomics Inc Recent Developments/Updates
6.8 Eli Lilly and Co
6.8.1 Eli Lilly and Co Company Information
6.8.2 Eli Lilly and Co Description and Business Overview
6.8.3 Eli Lilly and Co Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Eli Lilly and Co Transforming Growth Factor Beta 1 Product Portfolio
6.8.5 Eli Lilly and Co Recent Developments/Updates
6.9 Formation Biologics Inc
6.9.1 Formation Biologics Inc Company Information
6.9.2 Formation Biologics Inc Description and Business Overview
6.9.3 Formation Biologics Inc Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Formation Biologics Inc Transforming Growth Factor Beta 1 Product Portfolio
6.9.5 Formation Biologics Inc Recent Developments/Updates
6.10 Novartis AG
6.10.1 Novartis AG Company Information
6.10.2 Novartis AG Description and Business Overview
6.10.3 Novartis AG Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Novartis AG Transforming Growth Factor Beta 1 Product Portfolio
6.10.5 Novartis AG Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Transforming Growth Factor Beta 1 Industry Chain Analysis
7.2 Transforming Growth Factor Beta 1 Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Transforming Growth Factor Beta 1 Production Mode & Process Analysis
7.4 Transforming Growth Factor Beta 1 Sales and Marketing
7.4.1 Transforming Growth Factor Beta 1 Sales Channels
7.4.2 Transforming Growth Factor Beta 1 Distributors
7.5 Transforming Growth Factor Beta 1 Customer Analysis
8 Transforming Growth Factor Beta 1 Market Dynamics
8.1 Transforming Growth Factor Beta 1 Industry Trends
8.2 Transforming Growth Factor Beta 1 Market Drivers
8.3 Transforming Growth Factor Beta 1 Market Challenges
8.4 Transforming Growth Factor Beta 1 Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Transforming Growth Factor Beta 1 Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Transforming Growth Factor Beta 1 Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Transforming Growth Factor Beta 1 Market Competitive Situation by Manufacturers in 2024
Table 4. Global Transforming Growth Factor Beta 1 Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Transforming Growth Factor Beta 1 Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Transforming Growth Factor Beta 1 Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Transforming Growth Factor Beta 1 Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Transforming Growth Factor Beta 1 Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Transforming Growth Factor Beta 1, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Transforming Growth Factor Beta 1, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Transforming Growth Factor Beta 1, Product Type & Application
Table 12. Global Key Manufacturers of Transforming Growth Factor Beta 1, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Transforming Growth Factor Beta 1 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transforming Growth Factor Beta 1 as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Transforming Growth Factor Beta 1 Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Transforming Growth Factor Beta 1 Sales by Region (2020-2025) & (K Units)
Table 18. Global Transforming Growth Factor Beta 1 Sales Market Share by Region (2020-2025)
Table 19. Global Transforming Growth Factor Beta 1 Sales by Region (2026-2031) & (K Units)
Table 20. Global Transforming Growth Factor Beta 1 Sales Market Share by Region (2026-2031)
Table 21. Global Transforming Growth Factor Beta 1 Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Transforming Growth Factor Beta 1 Revenue Market Share by Region (2020-2025)
Table 23. Global Transforming Growth Factor Beta 1 Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Transforming Growth Factor Beta 1 Revenue Market Share by Region (2026-2031)
Table 25. North America Transforming Growth Factor Beta 1 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Transforming Growth Factor Beta 1 Sales by Country (2020-2025) & (K Units)
Table 27. North America Transforming Growth Factor Beta 1 Sales by Country (2026-2031) & (K Units)
Table 28. North America Transforming Growth Factor Beta 1 Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Transforming Growth Factor Beta 1 Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Transforming Growth Factor Beta 1 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Transforming Growth Factor Beta 1 Sales by Country (2020-2025) & (K Units)
Table 32. Europe Transforming Growth Factor Beta 1 Sales by Country (2026-2031) & (K Units)
Table 33. Europe Transforming Growth Factor Beta 1 Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Transforming Growth Factor Beta 1 Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Transforming Growth Factor Beta 1 Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Transforming Growth Factor Beta 1 Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Transforming Growth Factor Beta 1 Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Transforming Growth Factor Beta 1 Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Transforming Growth Factor Beta 1 Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Transforming Growth Factor Beta 1 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Transforming Growth Factor Beta 1 Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Transforming Growth Factor Beta 1 Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Transforming Growth Factor Beta 1 Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Transforming Growth Factor Beta 1 Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Transforming Growth Factor Beta 1 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Transforming Growth Factor Beta 1 Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Transforming Growth Factor Beta 1 Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Transforming Growth Factor Beta 1 Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Transforming Growth Factor Beta 1 Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Transforming Growth Factor Beta 1 Sales (K Units) by Type (2020-2025)
Table 51. Global Transforming Growth Factor Beta 1 Sales (K Units) by Type (2026-2031)
Table 52. Global Transforming Growth Factor Beta 1 Sales Market Share by Type (2020-2025)
Table 53. Global Transforming Growth Factor Beta 1 Sales Market Share by Type (2026-2031)
Table 54. Global Transforming Growth Factor Beta 1 Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Transforming Growth Factor Beta 1 Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Transforming Growth Factor Beta 1 Revenue Market Share by Type (2020-2025)
Table 57. Global Transforming Growth Factor Beta 1 Revenue Market Share by Type (2026-2031)
Table 58. Global Transforming Growth Factor Beta 1 Price (USD/Unit) by Type (2020-2025)
Table 59. Global Transforming Growth Factor Beta 1 Price (USD/Unit) by Type (2026-2031)
Table 60. Global Transforming Growth Factor Beta 1 Sales (K Units) by Application (2020-2025)
Table 61. Global Transforming Growth Factor Beta 1 Sales (K Units) by Application (2026-2031)
Table 62. Global Transforming Growth Factor Beta 1 Sales Market Share by Application (2020-2025)
Table 63. Global Transforming Growth Factor Beta 1 Sales Market Share by Application (2026-2031)
Table 64. Global Transforming Growth Factor Beta 1 Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Transforming Growth Factor Beta 1 Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Transforming Growth Factor Beta 1 Revenue Market Share by Application (2020-2025)
Table 67. Global Transforming Growth Factor Beta 1 Revenue Market Share by Application (2026-2031)
Table 68. Global Transforming Growth Factor Beta 1 Price (USD/Unit) by Application (2020-2025)
Table 69. Global Transforming Growth Factor Beta 1 Price (USD/Unit) by Application (2026-2031)
Table 70. Roche Company Information
Table 71. Roche Description and Business Overview
Table 72. Roche Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Roche Transforming Growth Factor Beta 1 Product
Table 74. Roche Recent Developments/Updates
Table 75. Shionogi Ltd Company Information
Table 76. Shionogi Ltd Description and Business Overview
Table 77. Shionogi Ltd Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Shionogi Ltd Transforming Growth Factor Beta 1 Product
Table 79. Shionogi Ltd Recent Developments/Updates
Table 80. Acceleron Pharma Inc Company Information
Table 81. Acceleron Pharma Inc Description and Business Overview
Table 82. Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Acceleron Pharma Inc Transforming Growth Factor Beta 1 Product
Table 84. Acceleron Pharma Inc Recent Developments/Updates
Table 85. Genzyme Corp Company Information
Table 86. Genzyme Corp Description and Business Overview
Table 87. Genzyme Corp Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Genzyme Corp Transforming Growth Factor Beta 1 Product
Table 89. Genzyme Corp Recent Developments/Updates
Table 90. Isarna Therapeutics GmbH Company Information
Table 91. Isarna Therapeutics GmbH Description and Business Overview
Table 92. Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Product
Table 94. Isarna Therapeutics GmbH Recent Developments/Updates
Table 95. Scholar Rock Company Information
Table 96. Scholar Rock Description and Business Overview
Table 97. Scholar Rock Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Scholar Rock Transforming Growth Factor Beta 1 Product
Table 99. Scholar Rock Recent Developments/Updates
Table 100. Sirnaomics Inc Company Information
Table 101. Sirnaomics Inc Description and Business Overview
Table 102. Sirnaomics Inc Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Sirnaomics Inc Transforming Growth Factor Beta 1 Product
Table 104. Sirnaomics Inc Recent Developments/Updates
Table 105. Eli Lilly and Co Company Information
Table 106. Eli Lilly and Co Description and Business Overview
Table 107. Eli Lilly and Co Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Eli Lilly and Co Transforming Growth Factor Beta 1 Product
Table 109. Eli Lilly and Co Recent Developments/Updates
Table 110. Formation Biologics Inc Company Information
Table 111. Formation Biologics Inc Description and Business Overview
Table 112. Formation Biologics Inc Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Formation Biologics Inc Transforming Growth Factor Beta 1 Product
Table 114. Formation Biologics Inc Recent Developments/Updates
Table 115. Novartis AG Company Information
Table 116. Novartis AG Description and Business Overview
Table 117. Novartis AG Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Novartis AG Transforming Growth Factor Beta 1 Product
Table 119. Novartis AG Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Transforming Growth Factor Beta 1 Distributors List
Table 123. Transforming Growth Factor Beta 1 Customers List
Table 124. Transforming Growth Factor Beta 1 Market Trends
Table 125. Transforming Growth Factor Beta 1 Market Drivers
Table 126. Transforming Growth Factor Beta 1 Market Challenges
Table 127. Transforming Growth Factor Beta 1 Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Transforming Growth Factor Beta 1
Figure 2. Global Transforming Growth Factor Beta 1 Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Transforming Growth Factor Beta 1 Market Share by Type: 2024 & 2031
Figure 4. Pirfenidone Product Picture
Figure 5. Galunisertib Product Picture
Figure 6. Others Product Picture
Figure 7. Global Transforming Growth Factor Beta 1 Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Transforming Growth Factor Beta 1 Market Share by Application: 2024 & 2031
Figure 9. IPF
Figure 10. Cancer
Figure 11. Others
Figure 12. Global Transforming Growth Factor Beta 1 Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Transforming Growth Factor Beta 1 Market Size (2020-2031) & (US$ Million)
Figure 14. Global Transforming Growth Factor Beta 1 Sales (2020-2031) & (K Units)
Figure 15. Global Transforming Growth Factor Beta 1 Average Price (USD/Unit) & (2020-2031)
Figure 16. Transforming Growth Factor Beta 1 Report Years Considered
Figure 17. Transforming Growth Factor Beta 1 Sales Share by Manufacturers in 2024
Figure 18. Global Transforming Growth Factor Beta 1 Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Transforming Growth Factor Beta 1 Players: Market Share by Revenue in Transforming Growth Factor Beta 1 in 2024
Figure 20. Transforming Growth Factor Beta 1 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Transforming Growth Factor Beta 1 Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Transforming Growth Factor Beta 1 Sales Market Share by Country (2020-2031)
Figure 23. North America Transforming Growth Factor Beta 1 Revenue Market Share by Country (2020-2031)
Figure 24. U.S. Transforming Growth Factor Beta 1 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Transforming Growth Factor Beta 1 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Transforming Growth Factor Beta 1 Sales Market Share by Country (2020-2031)
Figure 27. Europe Transforming Growth Factor Beta 1 Revenue Market Share by Country (2020-2031)
Figure 28. Germany Transforming Growth Factor Beta 1 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Transforming Growth Factor Beta 1 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Transforming Growth Factor Beta 1 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Transforming Growth Factor Beta 1 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Transforming Growth Factor Beta 1 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Transforming Growth Factor Beta 1 Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Transforming Growth Factor Beta 1 Revenue Market Share by Region (2020-2031)
Figure 35. China Transforming Growth Factor Beta 1 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Transforming Growth Factor Beta 1 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Transforming Growth Factor Beta 1 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Transforming Growth Factor Beta 1 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Transforming Growth Factor Beta 1 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Transforming Growth Factor Beta 1 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Indonesia Transforming Growth Factor Beta 1 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Thailand Transforming Growth Factor Beta 1 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Malaysia Transforming Growth Factor Beta 1 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Transforming Growth Factor Beta 1 Sales Market Share by Country (2020-2031)
Figure 45. Latin America Transforming Growth Factor Beta 1 Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Transforming Growth Factor Beta 1 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Transforming Growth Factor Beta 1 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Transforming Growth Factor Beta 1 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Transforming Growth Factor Beta 1 Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Transforming Growth Factor Beta 1 Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Transforming Growth Factor Beta 1 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Transforming Growth Factor Beta 1 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Transforming Growth Factor Beta 1 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Transforming Growth Factor Beta 1 by Type (2020-2031)
Figure 55. Global Revenue Market Share of Transforming Growth Factor Beta 1 by Type (2020-2031)
Figure 56. Global Transforming Growth Factor Beta 1 Price (USD/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Transforming Growth Factor Beta 1 by Application (2020-2031)
Figure 58. Global Revenue Market Share of Transforming Growth Factor Beta 1 by Application (2020-2031)
Figure 59. Global Transforming Growth Factor Beta 1 Price (USD/Unit) by Application (2020-2031)
Figure 60. Transforming Growth Factor Beta 1 Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
